Literature DB >> 8289796

Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors.

C Y Wang1, A G Bassuk, L H Boise, C B Thompson, R Bravo, J M Leiden.   

Abstract

The granulocyte-macrophage colony-stimulating factor (GM-CSF) gene has been studied extensively as a model system of transcriptional induction during T-lymphocyte activation. The GM-CSF gene is not expressed in resting peripheral blood T cells but is rapidly induced at the transcriptional level following activation through the cell surface T-cell receptor. A highly conserved 19-bp element located immediately 5' of the human GM-CSF TATA box (bp -34 to -52), herein called purine box 1 (PB1), has been shown to bind a T-cell nuclear protein complex and to be required for transcriptional induction of the GM-CSF gene following T-cell activation. The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes. In this report, we demonstrate that the PB1 element alone confers inducibility on a heterologous promoter following transfection into human Jurkat T cells. In addition, we identify a major PB1 nuclear protein-binding complex that is not present in resting peripheral blood T cells but is rapidly induced following T-cell activation. Sequence analysis revealed that PB1 is composed of adjacent binding sites for Ets and AP-1 transcription factors. In vitro mutagenesis experiments demonstrated that both the Ets and AP-1 sites are required for binding of the inducible PB1 nuclear protein complex and for the transcriptional activity of this element and the GM-CSF promoter in activated T cells. Using antibodies specific for different Ets and AP-1 family members, we demonstrate that the major inducible PB1-binding activity present in activated T-cell nuclear extracts is composed of the Elf-1, c-Fos, and JunB transcription factors. Taken together, these results suggest that cooperative interactions between specific Ets and AP-1 family members are important in regulating inducible gene expression following T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289796      PMCID: PMC358471          DOI: 10.1128/mcb.14.2.1153-1159.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  A T-cell-specific transcriptional enhancer element 3' of C alpha in the human T-cell receptor alpha locus.

Authors:  I C Ho; L H Yang; G Morle; J M Leiden
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

2.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

3.  Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein.

Authors:  C Y Wang; B Petryniak; C B Thompson; W G Kaelin; J M Leiden
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

4.  A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells.

Authors:  J M Leiden; C Y Wang; B Petryniak; D M Markovitz; G J Nabel; C B Thompson
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

5.  The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB.

Authors:  L H Boise; B Petryniak; X Mao; C H June; C Y Wang; T Lindsten; R Bravo; K Kovary; J M Leiden; C B Thompson
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins.

Authors:  K Kovary; R Bravo
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

7.  Nuclear factor of activated T cells contains Fos and Jun.

Authors:  J Jain; P G McCaffrey; V E Valge-Archer; A Rao
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

8.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Expression of human interleukin-3 (multi-CSF) is restricted to human lymphocytes and T-cell tumor lines.

Authors:  C M Niemeyer; C A Sieff; B Mathey-Prevot; J Z Wimperis; B E Bierer; S C Clark; D G Nathan
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

10.  Multiple mechanisms regulate c-myc gene expression during normal T cell activation.

Authors:  T Lindsten; C H June; C B Thompson
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  36 in total

1.  Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.

Authors:  James A McCubrey; Linda S Steelman; Richard A Franklin; Steven L Abrams; William H Chappell; Ellis W T Wong; Brian D Lehmann; David M Terrian; Jorg Basecke; Franca Stivala; Massimo Libra; Camilla Evangelisti; Alberto M Martelli
Journal:  Adv Enzyme Regul       Date:  2007-03-26

2.  Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy.

Authors:  James A McCubrey; Melissa L Sokolosky; Brian D Lehmann; Jackson R Taylor; Patrick M Navolanic; William H Chappell; Stephen L Abrams; Kristin M Stadelman; Ellis W T Wong; Negin Misaghian; Stefan Horn; Jörg Bäsecke; Massimo Libra; Franca Stivala; Giovanni Ligresti; Agostino Tafuri; Michele Milella; Marek Zarzycki; Andrzej Dzugaj; Francesca Chiarini; Camilla Evangelisti; Alberto M Martelli; David M Terrian; Richard A Franklin; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2008-02-21

Review 3.  Targeting signal transduction pathways to eliminate chemotherapeutic drug resistance and cancer stem cells.

Authors:  James A McCubrey; Stephen L Abrams; Kristin Stadelman; William H Chappell; Michelle Lahair; Richard A Ferland; Linda S Steelman
Journal:  Adv Enzyme Regul       Date:  2009-11-04

4.  The myeloid-cell-specific c-fes promoter is regulated by Sp1, PU.1, and a novel transcription factor.

Authors:  A Heydemann; G Juang; K Hennessy; M S Parmacek; M C Simon
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells.

Authors:  A G Bassuk; R T Anandappa; J M Leiden
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Cytokine regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by human retinal pigment epithelial cells.

Authors:  I J Crane; M C Kuppner; S McKillop-Smith; C A Wallace; J V Forrester
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

7.  Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes.

Authors:  Alla V Tsytsykova; Anne E Goldfeld
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts.

Authors:  Akira Andoh; Hirofumi Yasui; Osamu Inatomi; Zhuobin Zhang; Yasuyuki Deguchi; Kazunori Hata; Yoshio Araki; Tomoyuki Tsujikawa; Katsuyuki Kitoh; Shokei Kim-Mitsuyama; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

9.  Suppressive effect of Elf-1 on FcepsilonRI alpha-chain expression in primary mast cells.

Authors:  Qing-Hui Wang; Chiharu Nishiyama; Nobuhiro Nakano; Naomi Shimokawa; Mutsuko Hara; Shunsuke Kanada; Hideoki Ogawa; Ko Okumura
Journal:  Immunogenetics       Date:  2008-07-16       Impact factor: 2.846

10.  DNA specificity determinants associate with distinct transcription factor functions.

Authors:  Peter C Hollenhorst; Katherine J Chandler; Rachel L Poulsen; W Evan Johnson; Nancy A Speck; Barbara J Graves
Journal:  PLoS Genet       Date:  2009-12-18       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.